These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 6277235)

  • 1. Interaction of myasthenic immunoglobulins and cholinergic agonists on acetylcholine receptors of rat myotubes.
    Ashizawa T; Elias SB; Appel SH
    Ann Neurol; 1982 Jan; 11(1):22-7. PubMed ID: 6277235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A myasthenia gravis plasma immunoglobulin reduces miniature endplate potentials at human endplates in vitro.
    Burges J; Wray DW; Pizzighella S; Hall Z; Vincent A
    Muscle Nerve; 1990 May; 13(5):407-13. PubMed ID: 2345558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
    Cole RN; Reddel SW; Gervásio OL; Phillips WD
    Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of acetylcholine receptor antibodies in myasthenia gravis.
    Appel SH; Elias SB; Chauvin P
    Fed Proc; 1979 Sep; 38(10):2381-5. PubMed ID: 478014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lead-induced attenuation in the aggregation of acetylcholine receptors during the neuromuscular junction formation.
    Chen SS; Lin CH; Chen TJ
    Toxicol Lett; 2005 Oct; 159(1):89-99. PubMed ID: 15916872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Passive transfer of seronegative myasthenia gravis to mice.
    Burges J; Vincent A; Molenaar PC; Newsom-Davis J; Peers C; Wray D
    Muscle Nerve; 1994 Dec; 17(12):1393-400. PubMed ID: 7969240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of hyperacute experimental autoimmune myasthenia gravis. Acetylcholine receptor/cholinergic site/receptor function/autoimmunity.
    Mihovilovic M; Donnelly-Roberts D; Richman DP; Martinez-Carrion M
    J Immunol; 1994 Jun; 152(12):5997-6002. PubMed ID: 8207224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-Deazaadenosine: a therapeutic strategy for myasthenia gravis by decreasing the endocytosis of acetylcholine receptors.
    Kuncl RW; Drachman DB; Adams R; Lehar M
    J Pharmacol Exp Ther; 1993 Nov; 267(2):582-9. PubMed ID: 8246131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A modified assay for antibody against the nicotinic acetylcholine receptor in myasthenia gravis.
    Dwyer DS; Bradley RJ; Oh SJ; Kemp GE
    Clin Exp Immunol; 1979 Sep; 37(3):448-51. PubMed ID: 509779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetylcholine receptor in rabbit thymus: antigenic similarity between acetylcholine receptors of muscle and thymus.
    Ueno S; Wada K; Takahashi M; Tarui S
    Clin Exp Immunol; 1980 Dec; 42(3):463-9. PubMed ID: 7214741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunologic aspects of disorders of neuromuscular transmission. 2. Experimental autoimmune myasthenia gravis and the Lambert-Eaton myasthenic syndrome].
    Andreis I; Lovnićki TJ; Beara N; Taradi M
    Lijec Vjesn; 1994; 116(5-6):158-61. PubMed ID: 7968205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of junctional acetylcholine receptors in myasthenia gravis: clinical correlates.
    Pestronk A; Drachman DB; Self SG
    Muscle Nerve; 1985; 8(3):245-51. PubMed ID: 4058469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. alpha-Bungarotoxin displacing antibody in myasthenia gravis.
    Barkas T; Simpson JA
    J Clin Lab Immunol; 1982 Nov; 9(2):113-7. PubMed ID: 7154056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-and-down regulation of skeletal muscle acetylcholine receptors. Effects on neuromuscular blockers.
    Martyn JA; White DA; Gronert GA; Jaffe RS; Ward JM
    Anesthesiology; 1992 May; 76(5):822-43. PubMed ID: 1575351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymyositis: reduction of acetylcholine receptors in skeletal muscle.
    Pestronk A; Drachman DB
    Muscle Nerve; 1985; 8(3):233-9. PubMed ID: 4058467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neural agrin increases postsynaptic ACh receptor packing by elevating rapsyn protein at the mouse neuromuscular synapse.
    Brockhausen J; Cole RN; Gervásio OL; Ngo ST; Noakes PG; Phillips WD
    Dev Neurobiol; 2008 Aug; 68(9):1153-69. PubMed ID: 18506821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerated degradation of acetylcholine receptor from cultured rat myotubes with myasthenia gravis sera and globulins.
    Appel SH; Anwyl R; McAdams MW; Elias S
    Proc Natl Acad Sci U S A; 1977 May; 74(5):2130-4. PubMed ID: 266734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of myasthenic immunoglobulins against the lethal toxicity of alpha bungarotoxin.
    Vernet-der Garabedian B; Bach JF; Morel E
    Clin Exp Immunol; 1987 Apr; 68(1):130-7. PubMed ID: 3652512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.
    Hoch W; McConville J; Helms S; Newsom-Davis J; Melms A; Vincent A
    Nat Med; 2001 Mar; 7(3):365-8. PubMed ID: 11231638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of a myasthenic serum on the acetylcholine receptors of C2 myotubes. II. Functional inactivation of the receptor.
    Maricq AV; Gu Y; Hestrin S; Hall Z
    J Neurosci; 1985 Jul; 5(7):1917-24. PubMed ID: 2410577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.